1.47
price down icon2.65%   -0.04
after-market Dopo l'orario di chiusura: 1.45 -0.02 -1.36%
loading
Precedente Chiudi:
$1.51
Aprire:
$1.5
Volume 24 ore:
294.50K
Relative Volume:
0.31
Capitalizzazione di mercato:
$105.77M
Reddito:
-
Utile/perdita netta:
$-292.19M
Rapporto P/E:
-0.3238
EPS:
-4.54
Flusso di cassa netto:
$-208.41M
1 W Prestazione:
+2.08%
1M Prestazione:
+8.89%
6M Prestazione:
-33.78%
1 anno Prestazione:
-65.89%
Intervallo 1D:
Value
$1.46
$1.515
Intervallo di 1 settimana:
Value
$1.375
$1.52
Portata 52W:
Value
$1.01
$5.44

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Name
Nome
Zentalis Pharmaceuticals Inc
Name
Telefono
(858) 263-4333
Name
Indirizzo
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Name
Dipendente
166
Name
Cinguettio
@ZentalisP
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
ZNTL's Discussions on Twitter

Confronta ZNTL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ZNTL
Zentalis Pharmaceuticals Inc
1.47 102.89M 0 -292.19M -208.41M -4.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-12 Aggiornamento Wedbush Underperform → Neutral
2024-06-20 Downgrade UBS Buy → Neutral
2024-06-18 Downgrade Jefferies Buy → Hold
2024-06-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-06-18 Downgrade Wedbush Neutral → Underperform
2024-06-18 Downgrade Wells Fargo Overweight → Equal Weight
2023-11-08 Downgrade Wedbush Outperform → Neutral
2023-11-07 Downgrade Leerink Partners Outperform → Market Perform
2022-07-12 Iniziato Cowen Outperform
2022-04-06 Iniziato Wells Fargo Overweight
2021-10-07 Ripresa Jefferies Buy
2021-09-30 Iniziato Stifel Buy
2021-09-29 Iniziato Oppenheimer Outperform
2021-05-21 Iniziato UBS Buy
2021-01-20 Iniziato Wedbush Outperform
2020-09-29 Iniziato Cantor Fitzgerald Overweight
2020-08-27 Iniziato H.C. Wainwright Buy
2020-04-28 Iniziato Guggenheim Buy
2020-04-28 Iniziato Jefferies Buy
2020-04-28 Iniziato Morgan Stanley Overweight
2020-04-28 Iniziato SVB Leerink Outperform
Mostra tutto

Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie

pulisher
Jul 23, 2025

Is Zentalis Pharmaceuticals Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Zentalis Pharmaceuticals Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Zentalis Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Zentalis Pharmaceuticals Inc. stock priceExplosive trading opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 15, 2025

Why Zentalis Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Zentalis Pharmaceuticals Inc. stock price move sharplyHigh Return Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Zentalis Pharmaceuticals Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Insider Stock Buyers At Zentalis Pharmaceuticals Recouped Some Losses This Week - simplywall.st

Jul 14, 2025
pulisher
Jul 12, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Jul 12, 2025
pulisher
Jul 07, 2025

Wealth Enhancement Advisory Services LLC Purchases 33,958 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jul 07, 2025
pulisher
Jul 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Jul 01, 2025
pulisher
Jul 01, 2025

Zentalis Grants $1.19 Per Share Stock Options Package Under Nasdaq Compliance Rules - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 17, 2025
pulisher
Jun 12, 2025

Wealth Enhancement Advisory Services LLC Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Bank of America Corp DE - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Reduces Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Purchases New Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies - The Globe and Mail

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Lowers Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Why Did Zentalis Pharmaceuticals Inc. (ZNTL) Plunge 11.33%? - AInvest

Jun 05, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $1.94 Million Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Grows Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Sells 291,801 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ZNTL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Expands Cancer Research Team: 137K Share Options Granted to Key New Hires - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Presents Promising Study Results at ASCO - TipRanks

Jun 02, 2025
pulisher
Jun 01, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Acquired by Millennium Management LLC - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Northern Trust Corp Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 28, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Invests $534,000 in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Captrust Financial Advisors Buys New Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 23, 2025
pulisher
May 23, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Hold” by Analysts - Defense World

May 23, 2025
pulisher
May 23, 2025

Jane Street Group LLC Boosts Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 23, 2025
pulisher
May 20, 2025

Zentalis Pharmaceuticals at H.C. Wainwright BioConnect Conference - TipRanks

May 20, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Has $175,000 Stock Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Wedbush Issues Optimistic Outlook for ZNTL Earnings - Defense World

May 19, 2025
pulisher
May 17, 2025

Wedbush Reaffirms Neutral Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

May 17, 2025
pulisher
May 16, 2025

Zentalis Pharmaceuticals First Quarter 2025 Earnings: US$0.67 loss per share (vs US$0.14 profit in 1Q 2024) - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Zentalis Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 16, 2025

Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):